{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:22:34Z","timestamp":1793881354428,"version":"4.7.0"},"reference-count":27,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130036"],"award-info":[{"award-number":["82130036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301372"],"award-info":[{"award-number":["82301372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471217"],"award-info":[{"award-number":["82471217"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health","award":["ZKX24016"],"award-info":[{"award-number":["ZKX24016"]}]},{"name":"STI2030-Major Projects","award":["2022ZD0211800"],"award-info":[{"award-number":["2022ZD0211800"]}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","award":["2022-LCYJ-PY-11"],"award-info":[{"award-number":["2022-LCYJ-PY-11"]}],"id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["20221170"],"award-info":[{"award-number":["20221170"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["ZDXK202216"],"award-info":[{"award-number":["ZDXK202216"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Stroke Association","award":["JSSA20230010Y"],"award-info":[{"award-number":["JSSA20230010Y"]}]},{"name":"Jiangsu Province Stroke Association","award":["JSSA2024ZD01"],"award-info":[{"award-number":["JSSA2024ZD01"]}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["M2022107"],"award-info":[{"award-number":["M2022107"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2026,2,24]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cerebral small vessel disease (CSVD) represents a leading aetiology of vascular cognitive impairment, yet effective treatments for CSVD-related cognitive impairment (CSVD-CI) are limited. Although edaravone has shown potential in alleviating CSVD\u2019s pathophysiological changes, its efficacy in CSVD-CI remains underexplored, partly due to the lack of a suitable long-term dosage form.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This trial aims to assess the efficacy and safety of edaravone sublingual tablets (EST) for cognitive impairment in patients with CSVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and design<\/jats:title>\n                    <jats:p>This multicentre, randomised, double-blind, placebo-controlled trial will enrol patients with CSVD-CI, randomly assigning them to receive either EST or placebo for 24 weeks of treatment with concurrent follow-up, followed by an additional 24-week post-treatment follow-up period. Cognitive function, safety, MRI-based CSVD burden, cerebral arterial endothelial function and immune-mediated inflammation will be assessed. The primary outcome is the between-group difference in Montreal Cognitive Assessment score changes from baseline to week 48, along with adverse event incidence. Secondary outcomes include changes in cognitive domain scores, CSVD burden, deep regional cerebral perfusion and levels of glial fibrillar acidic protein (GFAP), neurofilament light chain and inflammatory factors in peripheral blood from baseline to weeks 24 and 48.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This trial will evaluate the efficacy and safety of EST in patients with CSVD-CI, potentially offering a new treatment strategy for this condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/svn-2025-004198","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:35:17Z","timestamp":1773246917000},"page":"svn-2025-004198","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of edaravone sublingual tablet for patients with cerebral small vessel disease-related cognitive impairment: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial"],"prefix":"10.1136","author":[{"given":"Qing","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Rong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-0319","authenticated-orcid":false,"given":"Yun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China"},{"name":"Department of Neurology, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, China"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China"},{"name":"Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China"},{"name":"Nanjing Neurology Clinical Medical Center, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2026041510001303000_svn-2025-004198v2.1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.19943"},{"key":"2026041510001303000_svn-2025-004198v2.2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.17219\/acem\/131216","article-title":"Cerebral small vessel disease: A review","volume":"30","author":"Chojdak-\u0141ukasiewicz","year":"2021","journal-title":"Adv Clin Exp Med"},{"key":"2026041510001303000_svn-2025-004198v2.3","doi-asserted-by":"crossref","first-page":"107299","DOI":"10.1016\/j.clineuro.2022.107299","article-title":"Edaravone for acute ischemic stroke - Systematic review with meta-analysis","volume":"219","author":"Fidalgo","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"key":"2026041510001303000_svn-2025-004198v2.4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s13760-024-02476-2","article-title":"Edaravone for patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"124","author":"Huang","year":"2024","journal-title":"Acta Neurol Belg"},{"key":"2026041510001303000_svn-2025-004198v2.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-023-00640-5","article-title":"Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease","volume":"18","author":"Inoue","year":"2023","journal-title":"Mol Neurodegener"},{"key":"2026041510001303000_svn-2025-004198v2.6","doi-asserted-by":"crossref","first-page":"148917","DOI":"10.1016\/j.brainres.2024.148917","article-title":"Edaravone dexborneol attenuates cognitive impairment in a rat model of vascular dementia by inhibiting hippocampal oxidative stress and inflammatory responses and modulating the NMDA receptor signaling pathway","volume":"1833","author":"Guo","year":"2024","journal-title":"Brain Res"},{"key":"2026041510001303000_svn-2025-004198v2.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.04.065"},{"key":"2026041510001303000_svn-2025-004198v2.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.02.007"},{"key":"2026041510001303000_svn-2025-004198v2.9","first-page":"24","article-title":"New Oral Form for ALS Drug","volume":"122","author":"Aschenbrenner","year":"2022","journal-title":"Am J Nurs"},{"key":"2026041510001303000_svn-2025-004198v2.10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/14737175.2023.2251687","article-title":"Oral Edaravone - Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis","volume":"23","author":"Pattee","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"2026041510001303000_svn-2025-004198v2.11","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27768"},{"key":"2026041510001303000_svn-2025-004198v2.12","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-024-03381-w","article-title":"Cost-utility analysis for sublingual versus intravenous edaravone in the treatment of amyotrophic lateral sclerosis","volume":"19","author":"Liu","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"2026041510001303000_svn-2025-004198v2.13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.clinthera.2020.01.006","article-title":"Predicting the Pharmacokinetic Characteristics of Edaravone Intravenous Injection and Sublingual Tablet Through Modeling and Simulation","volume":"42","author":"Chen","year":"2020","journal-title":"Clin Ther"},{"key":"2026041510001303000_svn-2025-004198v2.14","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.clinthera.2018.08.009","article-title":"Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers","volume":"40","author":"Wang","year":"2018","journal-title":"Clin Ther"},{"key":"2026041510001303000_svn-2025-004198v2.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00131-X"},{"key":"2026041510001303000_svn-2025-004198v2.16","doi-asserted-by":"crossref","first-page":"106709","DOI":"10.1016\/j.nbd.2024.106709","article-title":"A timeline study on vascular co-morbidity induced cerebral endothelial dysfunction assessed by perfusion MRI","volume":"202","author":"Callewaert","year":"2024","journal-title":"Neurobiol Dis"},{"key":"2026041510001303000_svn-2025-004198v2.17","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1161\/STROKEAHA.122.039277","article-title":"Association of Serum Cystatin C With Cerebral Small Vessel Disease in Community-Based Population","volume":"53","author":"Yao","year":"2022","journal-title":"Stroke"},{"key":"2026041510001303000_svn-2025-004198v2.18","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2022-002014"},{"key":"2026041510001303000_svn-2025-004198v2.19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaneurol.2023.5716","article-title":"Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke: The TASTE-SL Randomized Clinical Trial","volume":"81","author":"Fu","year":"2024","journal-title":"JAMA Neurol"},{"key":"2026041510001303000_svn-2025-004198v2.20","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.031197"},{"key":"2026041510001303000_svn-2025-004198v2.21","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-023-01253-2","article-title":"Differential response to donepezil in MRI subtypes of mild cognitive impairment","volume":"15","author":"Diaz-Galvan","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"2026041510001303000_svn-2025-004198v2.22","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-024-02807-0","article-title":"Cognitive and immunological effects of yoga compared to memory training in older women at risk for alzheimer\u2019s disease","volume":"14","author":"Grzenda","year":"2024","journal-title":"Transl Psychiatry"},{"key":"2026041510001303000_svn-2025-004198v2.23","first-page":"88","article-title":"Safety evaluation of edaravone sublingual tablets in Phase I clinical trials","volume":"18","author":"Zou","year":"2024","journal-title":"Jian Kang Zhong Gao"},{"key":"2026041510001303000_svn-2025-004198v2.24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/STROKEAHA.122.038265","article-title":"Cerebral Small Vessel Disease-Related Dementia: More Questions Than Answers","volume":"54","author":"Elahi","year":"2023","journal-title":"Stroke"},{"key":"2026041510001303000_svn-2025-004198v2.25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/2396987320920110","article-title":"Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease","volume":"5","author":"Wardlaw","year":"2020","journal-title":"Eur Stroke J"},{"key":"2026041510001303000_svn-2025-004198v2.26","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13888"},{"key":"2026041510001303000_svn-2025-004198v2.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-022-06646-6","article-title":"Efficacy and safety of Dengyinnaotong Capsule in patients with Cognitive impairment caused by cerebral Small Vessel Disease: study protocol of a multicenter, randomized, open-label, controlled trial (De-CSVD trial)","volume":"23","author":"Li","year":"2022","journal-title":"Trials"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2025-004198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:00:22Z","timestamp":1776272422000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2025-004198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":27,"alternative-id":["10.1136\/svn-2025-004198"],"URL":"https:\/\/doi.org\/10.1136\/svn-2025-004198","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}